203191-10-0

203191-10-0 structure

Name: Recoflavone
Chemical Name: 2-[2-(3,4-dimethoxyphenyl)-5-methoxy-4-oxochromen-7-yl]oxyacetic acid
CAS Number: 203191-10-0
Molecular Formula: C₂₀H₁₈O₈
Molecular Weight: 386.352
Catalog: Research Areas Cancer
Create Date: 2016-10-04 08:24:28
Modify Date: 2025-08-24 10:44:15
Recoflavone is a synthetic derivative of eupatilin that has a protective effect on gastric mucosa. Recoflavone has the potential to be used to treat peptic ulcer disease.

Name	2-[2-(3,4-dimethoxyphenyl)-5-methoxy-4-oxochromen-7-yl]oxyacetic acid
Synonyms	UNII-U96J5LG435 Recoflavone {[2-(3,4-Dimethoxyphenyl)-5-methoxy-4-oxo-4H-chromen-7-yl]oxy}acetic acid 7-Carboxymethoxyloxy-3',4',5-trimethoxyflavone DA-6034 Acetic acid, 2-[[2-(3,4-dimethoxyphenyl)-5-methoxy-4-oxo-4H-1-benzopyran-7-yl]oxy]-

Description	Recoflavone is a synthetic derivative of eupatilin that has a protective effect on gastric mucosa. Recoflavone has the potential to be used to treat peptic ulcer disease.
Related Catalog	Research Areas >> Cancer Research Areas >> Inflammation/Immunology
References	[1]. Choi SM, Seo MJ, Lee YG, et al. Effects of DA-6034, a flavonoid derivative, on mucin-like glycoprotein and ocular surface integrity in a rabbit model. Arzneimittelforschung. 2009;59(10):498-503. [2]. Kwak DS, Lee OY, Lee KN, et al. The Effect of DA-6034 on Intestinal Permeability in an Indomethacin-Induced Small Intestinal Injury Model. Gut Liver. 2016;10(3):406-411. [3]. Kim YW, Lee WH, Choi SM, et al. DA6034 promotes gastric epithelial cell migration and wound-healing through the mTOR pathway. J Gastroenterol Hepatol. 2012;27(2):397-405. [4]. Nam SY, Kim JS, Kim JM, et al. DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis. Exp Biol Med (Maywood). 2008;233(2):180-191.

847909-46-0

~99%

203191-10-0

Literature: Dong-A Pharmaceutical Co., Ltd. Patent: WO2005/23244 A1, 2005 ; Location in patent: Page/Page column 32-33 ;

847909-43-7

~97%

203191-10-0

Literature: Dong-A Pharmaceutical Co., Ltd. Patent: WO2005/23244 A1, 2005 ; Location in patent: Page/Page column 29 ;

118793-57-0

203191-10-0

Literature: Dong a Pharmaceutical Co., Ltd. Patent: US6025387 A1, 2000 ;

Precursor 3
847909-46-0 847909-43-7 118793-57-0
DownStream 0